zegalogue

Generic: dasiglucagon

Labeler: novo nordisk
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name zegalogue
Generic Name dasiglucagon
Labeler novo nordisk
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

dasiglucagon .6 mg/.6mL

Manufacturer
Novo Nordisk

Identifiers & Regulatory

Product NDC 0169-1912
Product ID 0169-1912_48d68219-2ba1-426f-a5a0-0cc35e69ff19
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA214231
Listing Expiration 2026-12-31
Marketing Start 2023-06-26

Pharmacologic Class

Established (EPC)
antihypoglycemic agent [epc]
Mechanism of Action
glucagon receptor agonists [moa]
Physiologic Effect
increased glycogenolysis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01691912
Hyphenated Format 0169-1912

Supplemental Identifiers

RxCUI
2535238 2535243 2535247 2535249
UNII
AD4J2O47FQ
NUI
N0000190852 N0000193923 N0000009345

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name zegalogue (source: ndc)
Generic Name dasiglucagon (source: ndc)
Application Number NDA214231 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • .6 mg/.6mL
source: ndc
Packaging
  • 1 CONTAINER in 1 PACKAGE (0169-1912-01) / 1 SYRINGE, GLASS in 1 CONTAINER / .6 mL in 1 SYRINGE, GLASS
  • 2 PACKAGE in 1 CARTON (0169-1912-02) / 1 CONTAINER in 1 PACKAGE (0169-1912-12) / 1 SYRINGE, GLASS in 1 CONTAINER / .6 mL in 1 SYRINGE, GLASS
source: ndc

Packages (2)

0169-1912-01 1 CONTAINER in 1 PACKAGE (0169-1912-01) / 1 SYRINGE, GLASS in 1 CONTAINER / .6 mL in 1 SYRINGE, GLASS 0169-1912-02 2 PACKAGE in 1 CARTON (0169-1912-02) / 1 CONTAINER in 1 PACKAGE (0169-1912-12) / 1 SYRINGE, GLASS in 1 CONTAINER / .6 mL in 1 SYRINGE, GLASS

Ingredients (1)

dasiglucagon (.6 mg/.6mL)

Linked Drug Pages (1)

Zegalogue ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "48d68219-2ba1-426f-a5a0-0cc35e69ff19", "openfda": {"nui": ["N0000190852", "N0000193923", "N0000009345"], "unii": ["AD4J2O47FQ"], "rxcui": ["2535238", "2535243", "2535247", "2535249"], "spl_set_id": ["14704879-872c-4967-8779-04a3bbdfb4e6"], "pharm_class_pe": ["Increased Glycogenolysis [PE]"], "pharm_class_epc": ["Antihypoglycemic Agent [EPC]"], "pharm_class_moa": ["Glucagon Receptor Agonists [MoA]"], "manufacturer_name": ["Novo Nordisk"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 CONTAINER in 1 PACKAGE (0169-1912-01)  / 1 SYRINGE, GLASS in 1 CONTAINER / .6 mL in 1 SYRINGE, GLASS", "package_ndc": "0169-1912-01", "marketing_start_date": "20230626"}, {"sample": false, "description": "2 PACKAGE in 1 CARTON (0169-1912-02)  / 1 CONTAINER in 1 PACKAGE (0169-1912-12)  / 1 SYRINGE, GLASS in 1 CONTAINER / .6 mL in 1 SYRINGE, GLASS", "package_ndc": "0169-1912-02", "marketing_start_date": "20230626"}], "brand_name": "Zegalogue", "product_id": "0169-1912_48d68219-2ba1-426f-a5a0-0cc35e69ff19", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Antihypoglycemic Agent [EPC]", "Glucagon Receptor Agonists [MoA]", "Increased Glycogenolysis [PE]"], "product_ndc": "0169-1912", "generic_name": "dasiglucagon", "labeler_name": "Novo Nordisk", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Zegalogue", "active_ingredients": [{"name": "DASIGLUCAGON", "strength": ".6 mg/.6mL"}], "application_number": "NDA214231", "marketing_category": "NDA", "marketing_start_date": "20230626", "listing_expiration_date": "20261231"}